Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro

Although thrombomodulin alfa (TM alfa), recombinant human soluble thrombomodulin, exerts antithrombogenic effects through activated protein C (APC), clinical trials suggested that TM alfa has a lower bleeding risk than does recombinant human APC. To address the mechanism explaining this difference,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Appl Thromb Hemost
Asıl Yazarlar: Tanaka, Kosuke, Tawara, Shunsuke, Tsuruta, Kazuhisa, Hoppensteadt, Debra, Fareed, Jawed
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714727/
https://ncbi.nlm.nih.gov/pubmed/29683037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029618770274
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller